schliessen

Filtern

 

Bibliotheken

Cover Image

Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study

Background: Findings on the association between the insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene and cardiovascular morbidity and mortality have been inconsistent. Considering the possible interaction between this polymorphism and smoking, we evaluated the... Full description

Journal Title: Journal of medical genetics 2005-01, Vol.42 (1), p.26-30
Main Author: Sayed-Tabatabaei, F A
Other Authors: Schut, A F C , Arias Vásquez, A , Bertoli-Avella, A M , Hofman, A , Witteman, J C M , van Duijn, C M
Format: Electronic Article Electronic Article
Language: English
Subjects:
80 and over
ACE
Aged
Aged, 80 and over
angiotensin
Angiotensin converting enzyme
angiotensin I-converting enzyme
Biological and medical sciences
Cardiology. Vascular system
cardiovascular disease
Cardiovascular Diseases
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - genetics
Cardiovascular Diseases - mortality
Cardiovascular Diseases/epidemiology/genetics/mortality
CHD
Cohort Studies
coronary heart disease
CVD
Dipeptidase A
epidemiology
Follow
Follow-Up Studies
General aspects. Genetic counseling
genes
Genetic
Genetic aspects
genetics
Genotype
Humans
I/D
IMT
insertion/deletion
intima media thickness
Introns
Medical genetics
Medical sciences
Middle Aged
Morbidity
mortality
Myocardial Infarction
Myocardial Infarction - epidemiology
Myocardial Infarction - genetics
Myocardial Infarction - mortality
Myocardial Infarction/epidemiology/genetics/mortality
Netherl
Netherlands - epidemiology
Original
Original Article
over
Peptidyl
Peptidyl-Dipeptidase A - genetics
Polymorphism
Polymorphism, Genetic
Research
Risk Factors
Smoking
Smoking - epidemiology
Time Factors
Up Studies
Quelle: Alma/SFX Local Collection
Publisher: London: BMJ Publishing Group Ltd
ID: ISSN: 0022-2593
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1735916
title: Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study
format: Article
creator:
  • Sayed-Tabatabaei, F A
  • Schut, A F C
  • Arias Vásquez, A
  • Bertoli-Avella, A M
  • Hofman, A
  • Witteman, J C M
  • van Duijn, C M
subjects:
  • 80 and over
  • ACE
  • Aged
  • Aged, 80 and over
  • angiotensin
  • Angiotensin converting enzyme
  • angiotensin I-converting enzyme
  • Biological and medical sciences
  • Cardiology. Vascular system
  • cardiovascular disease
  • Cardiovascular Diseases
  • Cardiovascular Diseases - epidemiology
  • Cardiovascular Diseases - genetics
  • Cardiovascular Diseases - mortality
  • Cardiovascular Diseases/epidemiology/genetics/mortality
  • CHD
  • Cohort Studies
  • coronary heart disease
  • CVD
  • Dipeptidase A
  • epidemiology
  • Follow
  • Follow-Up Studies
  • General aspects. Genetic counseling
  • genes
  • Genetic
  • Genetic aspects
  • genetics
  • Genotype
  • Humans
  • I/D
  • IMT
  • insertion/deletion
  • intima media thickness
  • Introns
  • Medical genetics
  • Medical sciences
  • Middle Aged
  • Morbidity
  • mortality
  • Myocardial Infarction
  • Myocardial Infarction - epidemiology
  • Myocardial Infarction - genetics
  • Myocardial Infarction - mortality
  • Myocardial Infarction/epidemiology/genetics/mortality
  • Netherl
  • Netherlands - epidemiology
  • Original
  • Original Article
  • over
  • Peptidyl
  • Peptidyl-Dipeptidase A - genetics
  • Polymorphism
  • Polymorphism, Genetic
  • Research
  • Risk Factors
  • Smoking
  • Smoking - epidemiology
  • Time Factors
  • Up Studies
ispartof: Journal of medical genetics, 2005-01, Vol.42 (1), p.26-30
description: Background: Findings on the association between the insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene and cardiovascular morbidity and mortality have been inconsistent. Considering the possible interaction between this polymorphism and smoking, we evaluated the association between ACE I/D polymorphism and myocardial infarction (MI), mortality due to coronary heart disease (CHD), and cardiovascular disease (CVD). Methods: The study was performed within the Rotterdam Study, a population based cohort study. The ACE I/D polymorphism was determined for 6714 participants and smoking status recorded at baseline. Fatal and non-fatal MIs and mortality events were regularly recorded. Cox proportional hazard analysis was performed separately for current smokers and non-smokers. We used age as the follow up time, presenting age specific survivals. Results: During follow up, 248 MIs and 301 and 482 deaths, respectively, due to CHD and CVD occurred. There were no significant differences between the genotypes as regards MI incidence. Among smokers, there was an increased risk of CHD and CVD mortality in carriers of the DD genotype compared to the II genotype, which diminished at later ages (p
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0022-2593
fulltext: fulltext
issn:
  • 0022-2593
  • 1468-6244
  • 1468-6244
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.2119765
LOCALfalse
PrimoNMBib
record
control
sourceidgale_pubme
recordidTN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1735916
sourceformatXML
sourcesystemPC
galeidA131305266
sourcerecordidA131305266
originalsourceidFETCH-LOGICAL-1664t-ec527524b27d11eade0bc57327aa8080247d1775819c63cf9c1a1f7e3fd244503
addsrcrecordideNqFkk1v1DAQhiMEoqVw5oYiITgg7dbfTnpAqlaUIlUF0cKBi-XYk10vib04ycLy6_FuVv3gUuVgzcwzY8-bN8teYjTFmIrjZTufEoTYFBEiuXiUHWImiokgjD3ODlHKTggv6UH2rOuWCGEqsXiaHWAuKEcSH2bh1M9d6MF3zucm-DXE3vl5Dv7vpoV8Dh7yVWg2bYirhevaXHubGx2tC2vdmaHRMU-1ylnXb3bFFPW6SdFJ3i8g_xr6HqLVbX7VD3bzPHtS66aDF_vzKPt29uF6dj65-Pzx0-z0YoKFYP0EDE_7EFYRaTEGbQFVhktKpNYFKhBhKS8lL3BpBDV1abDGtQRa27Q6R_Qoez_OXQ1VC9aA76Nu1Cq6VseNCtqp-xXvFmoe1gpLykss0oDLcUBYgdcuwr1e66FXFuywUr9rlYRVQCUrjGFWcgwlYYVlFKoKVRXBWqapR9nb_Yti-DVA16vWdQaaRnsIQ6eEpIxwIR4EsSwwKjBL4Ov_wGUYok-y7hjMi2KnxHSk5roB5Xwd0r4mfRZal_441C7lTzHFFHGyu_94bDAxdF2E-mZzjNTWdSq5Tm1dp0bXpY5Xd8W-5fc2S8CbPZA8o5s6am9cd8sJxjEpt4PQyHkd7wIwxJ3sEdINu8g3Kr2ElKllMra4roc_Nx06_twqKrm6_D5T-Mv52eyaXKkfiX838lW7fHCxf-WYDvQ
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid1781158850
display
typearticle
titleAngiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study
sourceAlma/SFX Local Collection
creatorSayed-Tabatabaei, F A ; Schut, A F C ; Arias Vásquez, A ; Bertoli-Avella, A M ; Hofman, A ; Witteman, J C M ; van Duijn, C M
creatorcontribSayed-Tabatabaei, F A ; Schut, A F C ; Arias Vásquez, A ; Bertoli-Avella, A M ; Hofman, A ; Witteman, J C M ; van Duijn, C M
descriptionBackground: Findings on the association between the insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene and cardiovascular morbidity and mortality have been inconsistent. Considering the possible interaction between this polymorphism and smoking, we evaluated the association between ACE I/D polymorphism and myocardial infarction (MI), mortality due to coronary heart disease (CHD), and cardiovascular disease (CVD). Methods: The study was performed within the Rotterdam Study, a population based cohort study. The ACE I/D polymorphism was determined for 6714 participants and smoking status recorded at baseline. Fatal and non-fatal MIs and mortality events were regularly recorded. Cox proportional hazard analysis was performed separately for current smokers and non-smokers. We used age as the follow up time, presenting age specific survivals. Results: During follow up, 248 MIs and 301 and 482 deaths, respectively, due to CHD and CVD occurred. There were no significant differences between the genotypes as regards MI incidence. Among smokers, there was an increased risk of CHD and CVD mortality in carriers of the DD genotype compared to the II genotype, which diminished at later ages (p<0.01 for gene-age interaction). Subgroup analysis in a younger and older group (based on the median age of 68.2 years) showed a significantly increased risk of CVD mortality in the younger group (hazard ratio = 5.19; 95% confidence interval: 1.15 to 23.42). Conclusions: This study showed that the ACE I/D polymorphism is not a strong risk factor for MI but its interaction with smoking might play a role in cardiovascular mortality especially at younger ages.
identifier
0ISSN: 0022-2593
1ISSN: 1468-6244
2EISSN: 1468-6244
3DOI: 10.1136/jmg.2004.022756
4PMID: 15635071
5CODEN: JMDGAE
languageeng
publisherLondon: BMJ Publishing Group Ltd
subject80 and over ; ACE ; Aged ; Aged, 80 and over ; angiotensin ; Angiotensin converting enzyme ; angiotensin I-converting enzyme ; Biological and medical sciences ; Cardiology. Vascular system ; cardiovascular disease ; Cardiovascular Diseases ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - genetics ; Cardiovascular Diseases - mortality ; Cardiovascular Diseases/epidemiology/genetics/mortality ; CHD ; Cohort Studies ; coronary heart disease ; CVD ; Dipeptidase A ; epidemiology ; Follow ; Follow-Up Studies ; General aspects. Genetic counseling ; genes ; Genetic ; Genetic aspects ; genetics ; Genotype ; Humans ; I/D ; IMT ; insertion/deletion ; intima media thickness ; Introns ; Medical genetics ; Medical sciences ; Middle Aged ; Morbidity ; mortality ; Myocardial Infarction ; Myocardial Infarction - epidemiology ; Myocardial Infarction - genetics ; Myocardial Infarction - mortality ; Myocardial Infarction/epidemiology/genetics/mortality ; Netherl ; Netherlands - epidemiology ; Original ; Original Article ; over ; Peptidyl ; Peptidyl-Dipeptidase A - genetics ; Polymorphism ; Polymorphism, Genetic ; Research ; Risk Factors ; Smoking ; Smoking - epidemiology ; Time Factors ; Up Studies
ispartofJournal of medical genetics, 2005-01, Vol.42 (1), p.26-30
rights
0Copyright 2005 Journal of Medical Genetics
1info:eu-repo/semantics/openAccess
22005 INIST-CNRS
3Copyright: 2005 Copyright 2005 Journal of Medical Genetics
lds50peer_reviewed
oafree_for_read
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16451296$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15635071$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Sayed-Tabatabaei, F A
1Schut, A F C
2Arias Vásquez, A
3Bertoli-Avella, A M
4Hofman, A
5Witteman, J C M
6van Duijn, C M
title
0Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study
1Journal of medical genetics
addtitleJ Med Genet
descriptionBackground: Findings on the association between the insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene and cardiovascular morbidity and mortality have been inconsistent. Considering the possible interaction between this polymorphism and smoking, we evaluated the association between ACE I/D polymorphism and myocardial infarction (MI), mortality due to coronary heart disease (CHD), and cardiovascular disease (CVD). Methods: The study was performed within the Rotterdam Study, a population based cohort study. The ACE I/D polymorphism was determined for 6714 participants and smoking status recorded at baseline. Fatal and non-fatal MIs and mortality events were regularly recorded. Cox proportional hazard analysis was performed separately for current smokers and non-smokers. We used age as the follow up time, presenting age specific survivals. Results: During follow up, 248 MIs and 301 and 482 deaths, respectively, due to CHD and CVD occurred. There were no significant differences between the genotypes as regards MI incidence. Among smokers, there was an increased risk of CHD and CVD mortality in carriers of the DD genotype compared to the II genotype, which diminished at later ages (p<0.01 for gene-age interaction). Subgroup analysis in a younger and older group (based on the median age of 68.2 years) showed a significantly increased risk of CVD mortality in the younger group (hazard ratio = 5.19; 95% confidence interval: 1.15 to 23.42). Conclusions: This study showed that the ACE I/D polymorphism is not a strong risk factor for MI but its interaction with smoking might play a role in cardiovascular mortality especially at younger ages.
subject
080 and over
1ACE
2Aged
3Aged, 80 and over
4angiotensin
5Angiotensin converting enzyme
6angiotensin I-converting enzyme
7Biological and medical sciences
8Cardiology. Vascular system
9cardiovascular disease
10Cardiovascular Diseases
11Cardiovascular Diseases - epidemiology
12Cardiovascular Diseases - genetics
13Cardiovascular Diseases - mortality
14Cardiovascular Diseases/epidemiology/genetics/mortality
15CHD
16Cohort Studies
17coronary heart disease
18CVD
19Dipeptidase A
20epidemiology
21Follow
22Follow-Up Studies
23General aspects. Genetic counseling
24genes
25Genetic
26Genetic aspects
27genetics
28Genotype
29Humans
30I/D
31IMT
32insertion/deletion
33intima media thickness
34Introns
35Medical genetics
36Medical sciences
37Middle Aged
38Morbidity
39mortality
40Myocardial Infarction
41Myocardial Infarction - epidemiology
42Myocardial Infarction - genetics
43Myocardial Infarction - mortality
44Myocardial Infarction/epidemiology/genetics/mortality
45Netherl
46Netherlands - epidemiology
47Original
48Original Article
49over
50Peptidyl
51Peptidyl-Dipeptidase A - genetics
52Polymorphism
53Polymorphism, Genetic
54Research
55Risk Factors
56Smoking
57Smoking - epidemiology
58Time Factors
59Up Studies
issn
00022-2593
11468-6244
21468-6244
fulltexttrue
rsrctypearticle
creationdate2005
recordtypearticle
recordideNqFkk1v1DAQhiMEoqVw5oYiITgg7dbfTnpAqlaUIlUF0cKBi-XYk10vib04ycLy6_FuVv3gUuVgzcwzY8-bN8teYjTFmIrjZTufEoTYFBEiuXiUHWImiokgjD3ODlHKTggv6UH2rOuWCGEqsXiaHWAuKEcSH2bh1M9d6MF3zucm-DXE3vl5Dv7vpoV8Dh7yVWg2bYirhevaXHubGx2tC2vdmaHRMU-1ylnXb3bFFPW6SdFJ3i8g_xr6HqLVbX7VD3bzPHtS66aDF_vzKPt29uF6dj65-Pzx0-z0YoKFYP0EDE_7EFYRaTEGbQFVhktKpNYFKhBhKS8lL3BpBDV1abDGtQRa27Q6R_Qoez_OXQ1VC9aA76Nu1Cq6VseNCtqp-xXvFmoe1gpLykss0oDLcUBYgdcuwr1e66FXFuywUr9rlYRVQCUrjGFWcgwlYYVlFKoKVRXBWqapR9nb_Yti-DVA16vWdQaaRnsIQ6eEpIxwIR4EsSwwKjBL4Ov_wGUYok-y7hjMi2KnxHSk5roB5Xwd0r4mfRZal_441C7lTzHFFHGyu_94bDAxdF2E-mZzjNTWdSq5Tm1dp0bXpY5Xd8W-5fc2S8CbPZA8o5s6am9cd8sJxjEpt4PQyHkd7wIwxJ3sEdINu8g3Kr2ElKllMra4roc_Nx06_twqKrm6_D5T-Mv52eyaXKkfiX838lW7fHCxf-WYDvQ
startdate200501
enddate200501
creator
0Sayed-Tabatabaei, F A
1Schut, A F C
2Arias Vásquez, A
3Bertoli-Avella, A M
4Hofman, A
5Witteman, J C M
6van Duijn, C M
general
0BMJ Publishing Group Ltd
1BMJ
2BMJ Publishing Group LTD
3BMJ Group
scope
0BSCLL
15DI
25DJ
3AGBBJ
4QVL
5IQODW
6CGR
7CUY
8CVF
9ECM
10EIF
11NPM
12AAYXX
13CITATION
14BSHEE
153V.
167X7
177XB
1888A
1988E
2088I
218AF
228FE
238FH
248FI
258FJ
268FK
27ABUWG
28AZQEC
29BBNVY
30BENPR
31BHPHI
32BTHHO
33DWQXO
34FYUFA
35GHDGH
36GNUQQ
37HCIFZ
38K9.
39LK8
40M0S
41M1P
42M2P
43M7P
44PQEST
45PQQKQ
46PQUKI
47PRINS
48Q9U
498FD
50FR3
51P64
52RC3
537X8
54BOBZL
55CLFQK
565PM
sort
creationdate200501
titleAngiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study
authorSayed-Tabatabaei, F A ; Schut, A F C ; Arias Vásquez, A ; Bertoli-Avella, A M ; Hofman, A ; Witteman, J C M ; van Duijn, C M
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1664t-ec527524b27d11eade0bc57327aa8080247d1775819c63cf9c1a1f7e3fd244503
rsrctypearticles
prefilterarticles
languageeng
creationdate2005
topic
080 and over
1ACE
2Aged
3Aged, 80 and over
4angiotensin
5Angiotensin converting enzyme
6angiotensin I-converting enzyme
7Biological and medical sciences
8Cardiology. Vascular system
9cardiovascular disease
10Cardiovascular Diseases
11Cardiovascular Diseases - epidemiology
12Cardiovascular Diseases - genetics
13Cardiovascular Diseases - mortality
14Cardiovascular Diseases/epidemiology/genetics/mortality
15CHD
16Cohort Studies
17coronary heart disease
18CVD
19Dipeptidase A
20epidemiology
21Follow
22Follow-Up Studies
23General aspects. Genetic counseling
24genes
25Genetic
26Genetic aspects
27genetics
28Genotype
29Humans
30I/D
31IMT
32insertion/deletion
33intima media thickness
34Introns
35Medical genetics
36Medical sciences
37Middle Aged
38Morbidity
39mortality
40Myocardial Infarction
41Myocardial Infarction - epidemiology
42Myocardial Infarction - genetics
43Myocardial Infarction - mortality
44Myocardial Infarction/epidemiology/genetics/mortality
45Netherl
46Netherlands - epidemiology
47Original
48Original Article
49over
50Peptidyl
51Peptidyl-Dipeptidase A - genetics
52Polymorphism
53Polymorphism, Genetic
54Research
55Risk Factors
56Smoking
57Smoking - epidemiology
58Time Factors
59Up Studies
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Sayed-Tabatabaei, F A
1Schut, A F C
2Arias Vásquez, A
3Bertoli-Avella, A M
4Hofman, A
5Witteman, J C M
6van Duijn, C M
collection
0Istex
1NARCIS
2NARCIS: Datasets
3Narcis: Open Access
4NARCIS:Publications
5Pascal-Francis
6Medline
7MEDLINE
8MEDLINE (Ovid)
9MEDLINE
10MEDLINE
11PubMed
12CrossRef
13Academic OneFile (A&I only)
14ProQuest Central (Corporate)
15Health & Medical Collection
16ProQuest Central (purchase pre-March 2016)
17Biology Database (Alumni Edition)
18Medical Database (Alumni Edition)
19Science Database (Alumni Edition)
20STEM Database
21ProQuest SciTech Collection
22ProQuest Natural Science Collection
23Hospital Premium Collection
24Hospital Premium Collection (Alumni Edition)
25ProQuest Central (Alumni) (purchase pre-March 2016)
26ProQuest Central (Alumni Edition)
27ProQuest Central Essentials
28Biological Science Collection
29ProQuest Central
30Natural Science Collection
31BMJ Journals
32ProQuest Central Korea
33Health Research Premium Collection
34Health Research Premium Collection (Alumni)
35ProQuest Central Student
36SciTech Premium Collection
37ProQuest Health & Medical Complete (Alumni)
38ProQuest Biological Science Collection
39Health & Medical Collection (Alumni Edition)
40Medical Database
41Science Database
42Biological Science Database
43ProQuest One Academic Eastern Edition
44ProQuest One Academic
45ProQuest One Academic UKI Edition
46ProQuest Central China
47ProQuest Central Basic
48Technology Research Database
49Engineering Research Database
50Biotechnology and BioEngineering Abstracts
51Genetics Abstracts
52MEDLINE - Academic
53OpenAIRE (Open Access)
54OpenAIRE
55PubMed Central (Full Participant titles)
jtitleJournal of medical genetics
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Sayed-Tabatabaei, F A
1Schut, A F C
2Arias Vásquez, A
3Bertoli-Avella, A M
4Hofman, A
5Witteman, J C M
6van Duijn, C M
formatjournal
genrearticle
ristypeJOUR
atitleAngiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study
jtitleJournal of medical genetics
addtitleJ Med Genet
date2005-01
risdate2005
volume42
issue1
spage26
epage30
pages26-30
issn
00022-2593
11468-6244
eissn1468-6244
codenJMDGAE
notesCorrespondence to:
 F A Sayed-Tabatabaei
 Department of Epidemiology and Biostatistics, Erasmus Medical Center, Postbus 1738, 3000 DR Rotterdam, The Netherlands;f.sayed@erasmusmc.nl
abstractBackground: Findings on the association between the insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene and cardiovascular morbidity and mortality have been inconsistent. Considering the possible interaction between this polymorphism and smoking, we evaluated the association between ACE I/D polymorphism and myocardial infarction (MI), mortality due to coronary heart disease (CHD), and cardiovascular disease (CVD). Methods: The study was performed within the Rotterdam Study, a population based cohort study. The ACE I/D polymorphism was determined for 6714 participants and smoking status recorded at baseline. Fatal and non-fatal MIs and mortality events were regularly recorded. Cox proportional hazard analysis was performed separately for current smokers and non-smokers. We used age as the follow up time, presenting age specific survivals. Results: During follow up, 248 MIs and 301 and 482 deaths, respectively, due to CHD and CVD occurred. There were no significant differences between the genotypes as regards MI incidence. Among smokers, there was an increased risk of CHD and CVD mortality in carriers of the DD genotype compared to the II genotype, which diminished at later ages (p<0.01 for gene-age interaction). Subgroup analysis in a younger and older group (based on the median age of 68.2 years) showed a significantly increased risk of CVD mortality in the younger group (hazard ratio = 5.19; 95% confidence interval: 1.15 to 23.42). Conclusions: This study showed that the ACE I/D polymorphism is not a strong risk factor for MI but its interaction with smoking might play a role in cardiovascular mortality especially at younger ages.
copLondon
pubBMJ Publishing Group Ltd
pmid15635071
doi10.1136/jmg.2004.022756
oafree_for_read